glp 1 trials GLP-1 receptor agonists and cardiovascular outcome trials: An update In the original clinical trials

The data from using these medications for weight loss are promising, with more studies currently being conducted for other uses like cardiovascular disease, fatty liver and substance use disorders

How long GLP-1-related constipation lasts largely depends on the dose and the individual, says Hamilton

The phenomenon isnt unique to GLP-1 therapy

2009;587(Pt 19):47494759

Their formulations are rooted in cutting-edge microbiome science and designed to support metabolism, gut barrier health, and even cravings while helping to maintain healthy blood sugar* by delivering next-generation, live probiotic strains to the gut

Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB